WA
DGX icon

WPG Advisers’s Quest Diagnostics DGX Stock Holding History

WPG Advisers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Hold
68
– – 0.01% 654
2026
Q1 		$13.3K Sell
68
-16
-19% -$3.11K 0.01% 590
2025
Q4 		$14.6K Sell
84
-69
-45% -$12.6K 0.01% 595
2025
Q3 		$29.2K Buy
153
+2
+1% +$355 0.02% 421
2025
Q2 		$27.1K Buy
151
+13
+9% +$2.26K 0.02% 423
2025
Q1 		$23.4K Buy
138
+103
+294% +$16.9K 0.02% 435
2024
Q4 		$5.28K Buy
+35
New +$5.44K ﹤0.01% 801

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

WPG Advisers's DGX Position: Q2 2026 in Review

WPG Advisers held its Quest Diagnostics (DGX) position steady in Q2 2026 at 68 shares worth $14.4K. The position accounts for 0.01% of the portfolio, ranked #654.

WPG Advisers first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.2K in Q3 2025. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • WPG Advisers held 68 shares of Quest Diagnostics worth $14.4K as of Q2 2026.
  • WPG Advisers left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #654 holding.
  • WPG Advisers first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Quest Diagnostics position peaked at $29.2K in Q3 2025.
  • 629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.